Zydus Wellness Limited (NSE:ZYDUSWELL)
India · Delayed Price · Currency is INR 600.45
-2.05 (-0.34%)
Jul 21, 2026, 10:10 AM IST
Zydus Wellness Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 39,610 | 27,089 | 23,278 | 22,548 | 20,091 | |
Revenue Growth (YoY) | 46.22% | 16.37% | 3.24% | 12.23% | 7.63% |
Cost of Revenue | 15,901 | 12,956 | 11,539 | 11,593 | 9,926 |
Gross Profit | 23,709 | 14,133 | 11,739 | 10,955 | 10,165 |
Selling, General & Admin | 10,598 | 6,893 | 5,691 | 4,991 | 4,626 |
Other Operating Expenses | 8,083 | 3,430 | 2,964 | 2,589 | 2,055 |
Operating Expenses | 20,152 | 10,615 | 8,896 | 7,830 | 6,944 |
Operating Income | 3,557 | 3,518 | 2,843 | 3,125 | 3,220 |
Interest Expense | -950 | -116 | -237 | -158 | -251.1 |
Interest & Investment Income | 14 | 31 | 110 | 32 | 92.9 |
Currency Exchange Gain (Loss) | 74 | -1 | 1 | -2 | -8.8 |
Other Non Operating Income (Expenses) | -19 | 3 | 1 | -2 | -4 |
EBT Excluding Unusual Items | 2,676 | 3,435 | 2,718 | 2,995 | 3,049 |
Merger & Restructuring Charges | -245 | - | - | - | - |
Gain (Loss) on Sale of Investments | 38 | 97 | 25 | 16 | 11.1 |
Gain (Loss) on Sale of Assets | -1 | -3 | - | -1 | -0.3 |
Other Unusual Items | -163 | 59 | -142 | -101 | - |
Pretax Income | 2,305 | 3,588 | 2,601 | 2,909 | 3,060 |
Income Tax Expense | 333 | 119 | -68 | -195 | -28.5 |
Earnings From Continuing Operations | 1,972 | 3,469 | 2,669 | 3,104 | 3,089 |
Net Income | 1,972 | 3,469 | 2,669 | 3,104 | 3,089 |
Net Income to Common | 1,972 | 3,469 | 2,669 | 3,104 | 3,089 |
Net Income Growth | -43.15% | 29.97% | -14.01% | 0.50% | 160.15% |
Shares Outstanding (Basic) | 318 | 318 | 318 | 318 | 318 |
Shares Outstanding (Diluted) | 318 | 318 | 318 | 318 | 318 |
Shares Change (YoY) | - | - | - | - | 4.76% |
EPS (Basic) | 6.20 | 10.90 | 8.39 | 9.76 | 9.71 |
EPS (Diluted) | 6.20 | 10.90 | 8.39 | 9.76 | 9.71 |
EPS Growth | -43.15% | 29.97% | -14.01% | 0.50% | 148.33% |
Free Cash Flow | 1,247 | 3,137 | 2,179 | 467 | 1,614 |
Free Cash Flow Per Share | 3.92 | 9.86 | 6.85 | 1.47 | 5.07 |
Dividend Per Share | 1.200 | 1.200 | 1.000 | 1.000 | 1.000 |
Dividend Growth | - | 20.00% | - | - | - |
Gross Margin | 59.86% | 52.17% | 50.43% | 48.59% | 50.59% |
Operating Margin | 8.98% | 12.99% | 12.21% | 13.86% | 16.03% |
Profit Margin | 4.98% | 12.81% | 11.47% | 13.77% | 15.37% |
Free Cash Flow Margin | 3.15% | 11.58% | 9.36% | 2.07% | 8.03% |
EBITDA | 4,977 | 3,776 | 3,033 | 3,333 | 3,403 |
EBITDA Margin | 12.57% | 13.94% | 13.03% | 14.78% | 16.94% |
D&A For EBITDA | 1,420 | 258 | 190 | 208 | 182.2 |
EBIT | 3,557 | 3,518 | 2,843 | 3,125 | 3,220 |
EBIT Margin | 8.98% | 12.99% | 12.21% | 13.86% | 16.03% |
Effective Tax Rate | 14.45% | 3.32% | - | - | - |
Revenue as Reported | 39,674 | 27,225 | 23,417 | 22,597 | 20,195 |
Advertising Expenses | 6,459 | 3,543 | 2,988 | 2,587 | 2,348 |